News
Filter
-
New Alzheimer’s treatment ‘lecanemab’ approved for use in the US
-
LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa
-
Catriona Crombie talks to Rare Revolution about LifeArc’s investment of more than £100 million into rare disease research by 2030
-
Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease
-
New UK-based research project brings together world-leading institutions to transform care for people living with dementia
-
LifeArc strengthens Board of Trustees with new appointments
-
How LifeArc’s Neurodegeneration Translational Challenge is leading the charge against Motor Neurone Disease
-
New programme to move potential MND drugs into clinical trials faster
-
LifeArc and Sarcoma UK fund research to guide treatment decisions in rare cancer
-
LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
-
Meet our industrial placement students – class of 2023
-
LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections
